Core Viewpoint - Recently, Kelong Botai Biopharmaceutical (Shanghai) Co., Ltd. was established with a registered capital of 5 million RMB, fully owned by Sichuan Kelong Botai Biopharmaceutical Co., Ltd. [1] Company Summary - The legal representative of Kelong Botai Biopharmaceutical (Shanghai) Co., Ltd. is Ding Nanchao [1] - The company operates in the field of scientific research and technical services, specifically in research and experimental development [1] - The registered address is located at 500 Lane 500, Furonghua Road, Pudong New District, Shanghai [1] - The company type is a limited liability company, wholly owned by a natural person [1] - The business scope includes medical research and experimental development (excluding human stem cells, gene diagnosis, and treatment technology development and application), import and export of goods, and technology import and export [1] Business Activities - The company is involved in various activities such as technical services, technical development, technical consulting, technical communication, technical transfer, and technical promotion [1] - It also organizes cultural and artistic exchange activities, conference and exhibition services (with overseas exhibitions subject to approval), marketing planning, corporate management consulting, and information technology consulting services [1]
科伦博泰生物医药（上海）有限公司成立，注册资本500万人民币